ONTOLOGY REPORT - ANNOTATIONS
| Term: | atomic nucleus |
|
| Accession: | CHEBI:33252
|
browse the term
|
| Definition: | A nucleus is the positively charged central portion of an atom, excluding the orbital electrons. |
| Synonyms: | exact_synonym: | nucleus |
| | related_synonym: | Atomkern; Kern; noyau; noyau atomique; nuclei; nucleo; nucleo atomico; nucleus atomi |
|
|
hydrogen peroxide
|
| G |
Aass |
aminoadipate-semialdehyde synthase |
|
affects expression |
ISO |
4 |
49,479,938 |
49,539,782 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abhd11 |
abhydrolase domain containing 11 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Acot11 |
acyl-CoA thioesterase 11 |
|
affects expression |
ISO |
5 |
127,820,932 |
127,870,633 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
affects expression |
ISO |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Actl7a |
actin-like 7a |
|
affects expression |
ISO |
5 |
74,649,956 |
74,651,431 |
RGD:6480464 |
CTD |
| G |
Actr3 |
ARP3 actin-related protein 3 homolog (yeast) |
|
affects expression |
ISO |
13 |
37,861,558 |
37,904,589 |
RGD:6480464 |
CTD |
| G |
Actr5 |
ARP5 actin-related protein 5 homolog (yeast) |
|
affects expression |
ISO |
3 |
149,357,984 |
149,371,469 |
RGD:6480464 |
CTD |
| G |
Actr6 |
ARP6 actin-related protein 6 homolog (yeast) |
|
affects expression |
ISO |
7 |
26,516,478 |
26,537,032 |
RGD:6480464 |
CTD |
| G |
Acyp1 |
acylphosphatase 1, erythrocyte (common) type |
|
affects expression |
ISO |
6 |
109,320,444 |
109,327,303 |
RGD:6480464 |
CTD |
| G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
multiple interactions |
ISO |
16 |
71,446,498 |
71,526,108 |
RGD:6480464 |
CTD |
| G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
multiple interactions |
ISO |
16 |
71,446,498 |
71,526,108 |
RGD:6480464 |
CTD |
| G |
Adam9 |
ADAM metallopeptidase domain 9 |
|
increases expression |
ISO |
16 |
71,446,498 |
71,526,108 |
RGD:6480464 |
CTD |
| G |
Adamts10 |
ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
|
decreases expression |
ISO |
7 |
16,043,150 |
16,059,666 |
RGD:6480464 |
CTD |
| G |
Adamts19 |
ADAM metallopeptidase with thrombospondin type 1 motif, 19 |
|
affects expression |
ISO |
18 |
54,660,288 |
54,847,297 |
RGD:6480464 |
CTD |
| G |
Adck1 |
aarF domain containing kinase 1 |
|
affects expression |
ISO |
6 |
111,872,315 |
111,992,613 |
RGD:6480464 |
CTD |
| G |
Adck5 |
aarF domain containing kinase 5 |
|
affects expression |
ISO |
7 |
114,630,171 |
114,647,984 |
RGD:6480464 |
CTD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
decreases expression |
ISO |
6 |
27,118,325 |
27,202,275 |
RGD:6480464 |
CTD |
| G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
|
affects expression |
ISO |
2 |
235,979,108 |
235,991,515 |
RGD:6480464 |
CTD |
| G |
Adh7 |
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
|
increases expression |
ISO |
2 |
235,749,346 |
235,765,063 |
RGD:6480464 |
CTD |
| G |
Adi1 |
acireductone dioxygenase 1 |
|
affects expression |
ISO |
6 |
46,552,589 |
46,559,551 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
affects expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
decreases expression |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adpn |
adiponutrin |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adss |
adenylosuccinate synthase |
|
affects expression |
ISO |
13 |
93,681,036 |
93,711,373 |
RGD:6480464 |
CTD |
| G |
Adssl1 |
adenylosuccinate synthase like 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aff1 |
AF4/FMR2 family, member 1 |
|
affects expression |
ISO |
14 |
7,015,191 |
7,114,671 |
RGD:6480464 |
CTD |
| G |
Aftph |
aftiphilin |
|
affects expression |
ISO |
14 |
101,482,829 |
101,536,786 |
RGD:6480464 |
CTD |
| G |
Agfg2 |
ArfGAP with FG repeats 2 |
|
affects expression |
ISO |
12 |
19,716,015 |
19,752,171 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
affects expression |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Agr3 |
anterior gradient 3 homolog (Xenopus laevis) |
|
affects expression |
ISO |
6 |
54,629,032 |
54,652,276 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases abundance |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases abundance |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agxt2l2 |
alanine-glyoxylate aminotransferase 2-like 2 |
|
affects expression |
ISO |
10 |
37,100,238 |
37,117,744 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
affects expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
multiple interactions |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Aifm2 |
apoptosis-inducing factor, mitochondrion-associated 2 |
|
multiple interactions |
EXP |
20 |
29,089,730 |
29,104,084 |
RGD:6480464 |
CTD |
| G |
Aifm2 |
apoptosis-inducing factor, mitochondrion-associated 2 |
|
increases secretion |
EXP |
20 |
29,089,730 |
29,104,084 |
RGD:6480464 |
CTD |
| G |
Aim1 |
absent in melanoma 1 |
|
affects expression |
ISO |
20 |
47,861,952 |
47,926,975 |
RGD:6480464 |
CTD |
| G |
Aimp1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
affects expression |
ISO |
2 |
230,142,679 |
230,166,226 |
RGD:6480464 |
CTD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
affects expression |
ISO |
1 |
20,573,215 |
20,704,564 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
increases expression |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
increases expression |
ISO |
17 |
77,034,737 |
77,081,406 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
affects expression |
ISO |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
multiple interactions |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
increases abundance |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
affects expression |
ISO |
14 |
19,126,935 |
19,142,214 |
RGD:6480464 |
CTD |
| G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
|
affects expression |
ISO |
1 |
223,731,675 |
223,773,285 |
RGD:6480464 |
CTD |
| G |
Aldh1b1 |
aldehyde dehydrogenase 1 family, member B1 |
|
affects expression |
ISO |
5 |
62,311,268 |
62,316,276 |
RGD:6480464 |
CTD |
| G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
|
affects expression |
ISO |
6 |
108,495,781 |
108,516,414 |
RGD:6480464 |
CTD |
| G |
Alg13 |
asparagine-linked glycosylation 13 |
|
affects expression |
ISO |
X |
34,184,163 |
34,192,061 |
RGD:6480464 |
CTD |
| G |
Alg5 |
ALG5, dolichyl-phosphate beta-glucosyltransferase |
|
affects expression |
ISO |
2 |
143,962,038 |
143,975,765 |
RGD:6480464 |
CTD |
| G |
Alk |
anaplastic lymphoma receptor tyrosine kinase |
|
increases phosphorylation |
ISO |
6 |
23,009,061 |
23,730,939 |
RGD:6480464 |
CTD |
| G |
Alms1 |
Alstrom syndrome 1 |
|
affects expression |
ISO |
4 |
119,846,037 |
119,946,085 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
increases activity |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
ISO |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
affects localization |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
multiple interactions |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5 |
arachidonate 5-lipoxygenase |
|
decreases activity |
EXP |
4 |
152,610,283 |
152,657,891 |
RGD:6480464 |
CTD |
| G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
increases expression |
ISO |
12 |
6,245,808 |
6,269,796 |
RGD:6480464 |
CTD |
| G |
Als2cr8 |
amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 8 |
|
affects expression |
ISO |
9 |
58,642,178 |
58,689,313 |
RGD:6480464 |
CTD |
| G |
Amd1 |
adenosylmethionine decarboxylase 1 |
|
affects expression |
ISO |
20 |
44,452,475 |
44,468,111 |
RGD:6480464 |
CTD |
| G |
Amica1 |
adhesion molecule, interacts with CXADR antigen 1 |
|
affects expression |
ISO |
8 |
48,034,107 |
48,058,837 |
RGD:6480464 |
CTD |
| G |
Amotl2 |
angiomotin like 2 |
|
affects expression |
ISO |
8 |
107,694,405 |
107,709,841 |
RGD:6480464 |
CTD |
| G |
Amph |
amphiphysin |
|
decreases expression |
ISO |
17 |
53,558,804 |
53,802,936 |
RGD:6480464 |
CTD |
| G |
Angpt1 |
angiopoietin 1 |
|
affects expression |
ISO |
7 |
78,195,504 |
78,451,471 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 |
|
affects expression |
ISO |
1 |
240,316,123 |
240,324,804 |
RGD:6480464 |
CTD |
| G |
Ankrd16 |
ankyrin repeat domain 16 |
|
affects expression |
ISO |
17 |
77,930,658 |
77,943,867 |
RGD:6480464 |
CTD |
| G |
Anln |
anillin, actin binding protein |
|
affects expression |
ISO |
8 |
21,642,021 |
21,721,815 |
RGD:6480464 |
CTD |
| G |
Anlnl1 |
anillin, actin binding protein-like 1 |
|
affects expression |
ISO |
17 |
68,547,371 |
68,559,629 |
RGD:6480464 |
CTD |
| G |
Anxa13 |
annexin A13 |
|
affects expression |
ISO |
7 |
95,071,045 |
95,123,201 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
affects expression |
ISO |
4 |
120,889,617 |
120,947,662 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatous polyposis coli |
|
decreases expression |
ISO |
18 |
26,732,147 |
26,790,383 |
RGD:6480464 |
CTD |
| G |
Apeh |
N-acylaminoacyl-peptide hydrolase |
|
decreases response to substance |
ISO |
8 |
113,353,151 |
113,362,263 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases response to substance |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Aph1b |
anterior pharynx defective 1 homolog B (C. elegans) |
|
affects expression |
ISO |
8 |
71,122,681 |
71,143,726 |
RGD:6480464 |
CTD |
| G |
Apoa4 |
apolipoprotein A-IV |
|
affects expression |
ISO |
8 |
49,233,142 |
49,233,431 |
RGD:6480464 |
CTD |
| G |
Apob |
apolipoprotein B |
|
affects expression |
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:6480464 |
CTD |
| G |
Apobec2 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
|
affects expression |
ISO |
9 |
7,947,500 |
7,961,013 |
RGD:6480464 |
CTD |
| G |
Apoc3 |
apolipoprotein C-III |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Apom |
apolipoprotein M |
|
affects expression |
ISO |
20 |
3,754,604 |
3,757,204 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
multiple interactions |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases expression |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
affects expression |
ISO |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Aqp11 |
aquaporin 11 |
|
affects expression |
ISO |
1 |
154,973,796 |
154,983,962 |
RGD:6480464 |
CTD |
| G |
Arap3 |
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 |
|
decreases secretion |
ISO |
18 |
30,893,720 |
30,916,965 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
affects expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Areg |
amphiregulin |
|
increases expression |
ISO |
14 |
18,466,313 |
18,475,571 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects expression |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgap22 |
Rho GTPase activating protein 22 |
|
affects expression |
ISO |
16 |
8,863,537 |
8,913,459 |
RGD:6480464 |
CTD |
| G |
Arhgap29 |
Rho GTPase activating protein 29 |
|
affects expression |
ISO |
2 |
218,619,428 |
218,679,087 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
decreases expression |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arhgef17 |
Rho guanine nucleotide exchange factor (GEF) 17 |
|
affects expression |
ISO |
1 |
158,316,868 |
158,375,737 |
RGD:6480464 |
CTD |
| G |
Arl4c |
ADP-ribosylation factor-like 4C |
|
affects expression |
ISO |
9 |
87,617,584 |
87,663,028 |
RGD:6480464 |
CTD |
| G |
Arl6ip5 |
ADP-ribosylation-like factor 6 interacting protein 5 |
|
multiple interactions |
ISO |
4 |
131,929,503 |
131,953,033 |
RGD:6480464 |
CTD |
| G |
Arl8b |
ADP-ribosylation factor-like 8B |
|
affects expression |
ISO |
4 |
144,299,366 |
144,344,431 |
RGD:6480464 |
CTD |
| G |
Armcx3 |
armadillo repeat containing, X-linked 3 |
|
affects expression |
ISO |
X |
122,217,524 |
122,221,077 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
increases expression |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
|
decreases expression |
ISO |
2 |
190,333,978 |
190,391,015 |
RGD:6480464 |
CTD |
| G |
Astn2 |
astrotactin 2 |
|
affects expression |
ISO |
5 |
82,124,461 |
83,128,927 |
RGD:6480464 |
CTD |
| G |
Atp2a2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
decreases expression |
EXP |
12 |
35,266,600 |
35,316,237 |
RGD:6480464 |
CTD |
| G |
Atp5b |
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide |
|
affects expression |
ISO |
7 |
1,376,552 |
1,383,228 |
RGD:6480464 |
CTD |
| G |
Atp5f1 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1 |
|
affects expression |
ISO |
2 |
201,195,390 |
201,206,585 |
RGD:6480464 |
CTD |
| G |
Atp6v1d |
ATPase, H+ transporting, lysosomal V1 subunit D |
|
affects expression |
ISO |
6 |
101,479,417 |
101,494,826 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
affects expression |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp8b3 |
ATPase, aminophospholipid transporter, class I, type 8B, member 3 |
|
affects expression |
ISO |
7 |
10,685,983 |
10,705,570 |
RGD:6480464 |
CTD |
| G |
Atxn1 |
ataxin 1 |
|
multiple interactions |
ISO |
17 |
24,719,383 |
25,138,270 |
RGD:6480464 |
CTD |
| G |
Atxn1 |
ataxin 1 |
|
affects localization |
ISO |
17 |
24,719,383 |
25,138,270 |
RGD:6480464 |
CTD |
| G |
Aurkb |
aurora kinase B |
|
decreases expression |
ISO |
10 |
55,798,710 |
55,804,367 |
RGD:6480464 |
CTD |
| G |
Avl9 |
AVL9 homolog (S. cerevisiase) |
|
increases expression |
ISO |
4 |
85,667,611 |
85,707,440 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
multiple interactions |
ISO |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
multiple interactions |
EXP |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
Axl |
Axl receptor tyrosine kinase |
|
increases phosphorylation |
EXP |
1 |
80,964,751 |
80,994,300 |
RGD:6480464 |
CTD |
| G |
B3gnt3 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
|
affects expression |
ISO |
16 |
18,892,320 |
18,901,908 |
RGD:6480464 |
CTD |
| G |
B3gnt5 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 |
|
affects expression |
ISO |
11 |
83,396,028 |
83,408,584 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
EXP |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bag2 |
Bcl2-associated athanogene 2 |
|
affects expression |
ISO |
9 |
32,491,167 |
32,493,678 |
RGD:6480464 |
CTD |
| G |
Bahcc1 |
BAH domain and coiled-coil containing 1 |
|
affects expression |
ISO |
10 |
109,726,243 |
109,735,724 |
RGD:6480464 |
CTD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
decreases expression |
ISO |
20 |
5,255,954 |
5,264,593 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
decreases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases activity |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
affects expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Baz2a |
bromodomain adjacent to zinc finger domain, 2A |
|
affects expression |
ISO |
7 |
1,389,681 |
1,421,170 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
Bcl-2 binding component 3 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bcar1 |
breast cancer anti-estrogen resistance 1 |
|
affects expression |
ISO |
19 |
41,646,190 |
41,669,234 |
RGD:6480464 |
CTD |
| G |
Bckdk |
branched chain ketoacid dehydrogenase kinase |
|
affects expression |
ISO |
1 |
187,189,665 |
187,194,336 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases response to substance |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects response to substance |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
increases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases response to substance |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l14 |
Bcl2-like 14 (apoptosis facilitator) |
|
affects expression |
ISO |
4 |
171,283,106 |
171,325,345 |
RGD:6480464 |
CTD |
| G |
Bcl3 |
B-cell CLL/lymphoma 3 |
|
affects expression |
ISO |
1 |
79,122,801 |
79,137,035 |
RGD:6480464 |
CTD |
| G |
Bcl6 |
B-cell CLL/lymphoma 6 |
|
affects expression |
ISO |
11 |
79,006,123 |
79,030,555 |
RGD:6480464 |
CTD |
| G |
Bclaf1 |
BCL2-associated transcription factor 1 |
|
affects expression |
ISO |
1 |
15,605,220 |
15,632,005 |
RGD:6480464 |
CTD |
| G |
Bcorl1 |
BCL6 co-repressor-like 1 |
|
affects expression |
ISO |
X |
134,755,840 |
134,802,339 |
RGD:6480464 |
CTD |
| G |
Bdh2 |
3-hydroxybutyrate dehydrogenase, type 2 |
|
affects expression |
ISO |
2 |
232,765,049 |
232,785,694 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
multiple interactions |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
increases expression |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Bfsp1 |
beaded filament structural protein 1, filensin |
|
affects expression |
ISO |
3 |
132,268,138 |
132,302,378 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
increases expression |
EXP |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Bin1 |
bridging integrator 1 |
|
multiple interactions |
ISO |
18 |
24,813,407 |
24,872,852 |
RGD:6480464 |
CTD |
| G |
Bin1 |
bridging integrator 1 |
|
affects expression |
ISO |
18 |
24,813,407 |
24,872,852 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bles03 |
basophilic leukemia expressed protein BLES03 |
|
affects expression |
ISO |
1 |
208,070,686 |
208,072,940 |
RGD:6480464 |
CTD |
| G |
Blm |
Bloom syndrome, RecQ helicase-like |
|
affects expression |
ISO |
1 |
136,271,573 |
136,358,077 |
RGD:6480464 |
CTD |
| G |
Blnk |
B-cell linker |
|
increases expression |
ISO |
1 |
246,091,335 |
246,165,075 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
decreases expression |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
affects expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
decreases expression |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
|
affects expression |
ISO |
15 |
46,516,626 |
46,539,756 |
RGD:6480464 |
CTD |
| G |
Bok |
BCL2-related ovarian killer |
|
affects expression |
ISO |
9 |
92,970,069 |
92,980,974 |
RGD:6480464 |
CTD |
| G |
Brca1 |
breast cancer 1, early onset |
|
decreases response to substance |
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:6480464 |
CTD |
| G |
Brd8 |
bromodomain containing 8 |
|
affects expression |
ISO |
18 |
27,074,235 |
27,094,586 |
RGD:6480464 |
CTD |
| G |
Bsdc1 |
BSD domain containing 1 |
|
affects expression |
ISO |
5 |
148,616,870 |
148,645,102 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
affects expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
ISO |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Btn2a2 |
butyrophilin, subfamily 2, member A2 |
|
affects expression |
ISO |
17 |
48,823,679 |
48,834,495 |
RGD:6480464 |
CTD |
| G |
C1qbp |
complement component 1, q subcomponent binding protein |
|
affects expression |
ISO |
10 |
57,881,783 |
57,886,434 |
RGD:6480464 |
CTD |
| G |
Calu |
calumenin |
|
affects expression |
ISO |
4 |
56,228,617 |
56,256,118 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
increases expression |
EXP |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capn2 |
calpain 2, (m/II) large subunit |
|
multiple interactions |
EXP |
13 |
98,473,367 |
98,524,463 |
RGD:6480464 |
CTD |
| G |
Capns1 |
calpain, small subunit 1 |
|
decreases expression |
ISO |
1 |
85,519,568 |
85,525,929 |
RGD:6480464 |
CTD |
| G |
Capns2 |
calpain, small subunit 2 |
|
affects expression |
ISO |
19 |
15,193,882 |
15,194,824 |
RGD:6480464 |
CTD |
| G |
Card10 |
caspase recruitment domain family, member 10 |
|
affects expression |
ISO |
7 |
116,737,928 |
116,766,959 |
RGD:6480464 |
CTD |
| G |
Carhsp1 |
calcium regulated heat stable protein 1 |
|
affects expression |
ISO |
10 |
6,986,583 |
7,000,181 |
RGD:6480464 |
CTD |
| G |
Cask |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
|
decreases expression |
ISO |
X |
20,910,960 |
21,250,869 |
RGD:6480464 |
CTD |
| G |
Casp1 |
caspase 1 |
|
increases activity |
ISO |
8 |
2,027,976 |
2,036,872 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
affects expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
decreases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp4 |
caspase 4, apoptosis-related cysteine peptidase |
|
affects expression |
ISO |
8 |
2,038,626 |
2,075,722 |
RGD:6480464 |
CTD |
| G |
Casp6 |
caspase 6 |
|
affects expression |
ISO |
2 |
227,361,538 |
227,373,844 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
multiple interactions |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases activity |
EXP |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases cleavage |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cast |
calpastatin |
|
affects expression |
ISO |
2 |
1,495,048 |
1,608,477 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects response to substance |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases response to substance |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
affects response to substance |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
increases expression |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
increases expression |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
multiple interactions |
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:6480464 |
CTD |
| G |
Cbfb |
core-binding factor, beta subunit |
|
affects expression |
ISO |
19 |
34,985,879 |
35,029,446 |
RGD:6480464 |
CTD |
| G |
Cblb |
Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
affects expression |
ISO |
11 |
49,690,402 |
49,856,762 |
RGD:6480464 |
CTD |
| G |
Cbx7 |
chromobox homolog 7 |
|
affects expression |
ISO |
7 |
118,148,413 |
118,165,701 |
RGD:6480464 |
CTD |
| G |
Ccdc150 |
coiled-coil domain containing 150 |
|
affects expression |
ISO |
9 |
53,085,922 |
53,172,920 |
RGD:6480464 |
CTD |
| G |
Ccdc28a |
coiled-coil domain containing 28A |
|
affects expression |
ISO |
1 |
13,269,164 |
13,284,200 |
RGD:6480464 |
CTD |
| G |
Ccdc38 |
coiled-coil domain containing 38 |
|
increases expression |
ISO |
7 |
30,601,969 |
30,643,967 |
RGD:6480464 |
CTD |
| G |
Cck |
cholecystokinin |
|
affects expression |
ISO |
8 |
126,492,636 |
126,499,220 |
RGD:6480464 |
CTD |
| G |
Cd33 |
CD33 molecule |
|
multiple interactions |
ISO |
1 |
93,904,033 |
93,910,383 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
increases mutagenesis |
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd59 |
CD59 molecule, complement regulatory protein |
|
increases mutagenesis |
ISO |
3 |
89,243,600 |
89,245,129 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
increases expression |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd97 |
CD97 molecule |
|
affects expression |
ISO |
19 |
26,089,268 |
26,108,997 |
RGD:6480464 |
CTD |
| G |
Cda |
cytidine deaminase |
|
affects expression |
ISO |
5 |
157,117,303 |
157,143,989 |
RGD:6480464 |
CTD |
| G |
Cdc16 |
cell division cycle 16 |
|
affects expression |
ISO |
16 |
80,628,131 |
80,650,925 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
decreases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
affects expression |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
decreases expression |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
affects expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
increases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdc42ep2 |
CDC42 effector protein (Rho GTPase binding) 2 |
|
affects expression |
ISO |
1 |
208,548,137 |
208,556,965 |
RGD:6480464 |
CTD |
| G |
Cdc5l |
cell division cycle 5-like |
|
affects expression |
ISO |
9 |
11,165,631 |
11,204,135 |
RGD:6480464 |
CTD |
| G |
Cdca2 |
cell division cycle associated 2 |
|
affects expression |
ISO |
15 |
47,225,711 |
47,271,412 |
RGD:6480464 |
CTD |
| G |
Cdh11 |
cadherin 11 |
|
decreases expression |
ISO |
19 |
2,225,209 |
2,382,805 |
RGD:6480464 |
CTD |
| G |
Cdh2 |
cadherin 2 |
|
decreases expression |
ISO |
18 |
8,048,920 |
8,267,974 |
RGD:6480464 |
CTD |
| G |
Cdh3 |
cadherin 3 |
|
decreases expression |
ISO |
19 |
36,343,823 |
36,393,819 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
affects expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk10 |
cyclin-dependent kinase 10 |
|
decreases expression |
ISO |
19 |
53,545,204 |
53,552,911 |
RGD:6480464 |
CTD |
| G |
Cdk15 |
cyclin-dependent kinase 15 |
|
affects expression |
ISO |
9 |
57,840,625 |
57,930,096 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases activity |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
affects expression |
ISO |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdk9 |
cyclin-dependent kinase 9 |
|
decreases expression |
ISO |
3 |
11,672,861 |
11,677,709 |
RGD:6480464 |
CTD |
| G |
Cdkl3 |
cyclin-dependent kinase-like 3 |
|
affects expression |
ISO |
10 |
37,527,865 |
37,552,851 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
affects expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cdrt4 |
CMT1A duplicated region transcript 4 |
|
affects expression |
ISO |
10 |
49,164,392 |
49,166,416 |
RGD:6480464 |
CTD |
| G |
Cdx2 |
caudal type homeo box 2 |
|
affects expression |
ISO |
12 |
8,296,103 |
8,303,643 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
affects expression |
ISO |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cebpg |
CCAAT/enhancer binding protein (C/EBP), gamma |
|
affects expression |
ISO |
1 |
87,552,695 |
87,559,447 |
RGD:6480464 |
CTD |
| G |
Cenpa |
centromere protein A |
|
decreases expression |
ISO |
6 |
25,686,603 |
25,693,840 |
RGD:6480464 |
CTD |
| G |
Cenpf |
centromere protein F |
|
affects expression |
ISO |
13 |
105,920,242 |
105,965,655 |
RGD:6480464 |
CTD |
| G |
Cenph |
centromere protein H |
|
affects expression |
ISO |
2 |
31,556,870 |
31,570,470 |
RGD:6480464 |
CTD |
| G |
Cep120 |
centrosomal protein 120 |
|
affects expression |
ISO |
18 |
49,192,432 |
49,255,022 |
RGD:6480464 |
CTD |
| G |
Cep89 |
centrosomal protein 89kDa |
|
affects expression |
ISO |
1 |
87,924,013 |
87,966,500 |
RGD:6480464 |
CTD |
| G |
Cetn2 |
centrin, EF-hand protein, 2 |
|
affects expression |
ISO |
X |
158,917,650 |
158,923,210 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
increases expression |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
decreases expression |
EXP |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
affects expression |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
affects expression |
ISO |
6 |
25,414,812 |
25,426,818 |
RGD:6480464 |
CTD |
| G |
Chd4 |
chromodomain helicase DNA binding protein 4 |
|
affects expression |
ISO |
4 |
161,217,964 |
161,251,018 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
decreases expression |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chsy1 |
chondroitin sulfate synthase 1 |
|
affects expression |
ISO |
1 |
120,539,002 |
120,600,102 |
RGD:6480464 |
CTD |
| G |
Cirh1a |
cirrhosis, autosomal recessive 1A (cirhin) |
|
affects expression |
ISO |
19 |
36,742,206 |
36,770,285 |
RGD:6480464 |
CTD |
| G |
Cish |
cytokine inducible SH2-containing protein |
|
affects expression |
ISO |
8 |
112,541,034 |
112,545,982 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
affects expression |
ISO |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
affects expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
multiple interactions |
EXP |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
decreases expression |
EXP |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
|
affects expression |
ISO |
1 |
206,802,745 |
206,806,332 |
RGD:6480464 |
CTD |
| G |
Cldn1 |
claudin 1 |
|
affects expression |
ISO |
11 |
76,473,654 |
76,488,809 |
RGD:6480464 |
CTD |
| G |
Cldn2 |
claudin 2 |
|
affects expression |
ISO |
X |
127,538,685 |
127,549,019 |
RGD:6480464 |
CTD |
| G |
Cldn23 |
claudin 23 |
|
affects expression |
ISO |
16 |
60,109,161 |
60,110,885 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn6 |
claudin 6 |
|
multiple interactions |
ISO |
10 |
12,944,503 |
12,947,271 |
RGD:6480464 |
CTD |
| G |
Cldn6 |
claudin 6 |
|
affects expression |
ISO |
10 |
12,944,503 |
12,947,271 |
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
affects expression |
ISO |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Cldn8 |
claudin 8 |
|
affects expression |
ISO |
11 |
28,419,612 |
28,421,861 |
RGD:6480464 |
CTD |
| G |
Cldn9 |
claudin 9 |
|
multiple interactions |
ISO |
10 |
12,947,423 |
12,948,854 |
RGD:6480464 |
CTD |
| G |
Cldn9 |
claudin 9 |
|
affects expression |
ISO |
10 |
12,947,423 |
12,948,854 |
RGD:6480464 |
CTD |
| G |
Cldnd1 |
claudin domain containing 1 |
|
affects expression |
ISO |
11 |
42,694,705 |
42,700,946 |
RGD:6480464 |
CTD |
| G |
Clic5 |
chloride intracellular channel 5 |
|
affects expression |
ISO |
9 |
12,370,341 |
12,472,969 |
RGD:6480464 |
CTD |
| G |
Clmp |
CXADR-like membrane protein |
|
affects expression |
ISO |
8 |
43,661,696 |
43,769,479 |
RGD:6480464 |
CTD |
| G |
Clptm1l |
CLPTM1-like |
|
affects expression |
ISO |
1 |
30,474,672 |
30,490,655 |
RGD:6480464 |
CTD |
| G |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
|
affects expression |
ISO |
8 |
119,149,810 |
119,165,515 |
RGD:6480464 |
CTD |
| G |
Cnksr3 |
Cnksr family member 3 |
|
affects expression |
ISO |
1 |
37,865,904 |
37,958,862 |
RGD:6480464 |
CTD |
| G |
Cnnm2 |
cyclin M2 |
|
affects expression |
ISO |
1 |
252,077,259 |
252,195,971 |
RGD:6480464 |
CTD |
| G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
|
affects expression |
ISO |
7 |
55,823,982 |
55,880,812 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
multiple interactions |
ISO |
1 |
215,842,668 |
215,844,691 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
decreases activity |
ISO |
1 |
215,842,668 |
215,844,691 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
multiple interactions |
ISO |
1 |
215,842,668 |
215,844,691 |
RGD:6480464 |
CTD |
| G |
Cog6 |
component of oligomeric golgi complex 6 |
|
affects expression |
ISO |
2 |
142,767,258 |
142,804,731 |
RGD:6480464 |
CTD |
| G |
Col16a1 |
collagen, type XVI, alpha 1 |
|
affects expression |
ISO |
5 |
149,072,905 |
149,126,350 |
RGD:6480464 |
CTD |
| G |
Col18a1 |
collagen, type XVIII, alpha 1 |
|
affects expression |
ISO |
20 |
11,920,816 |
11,982,468 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col9a3 |
collagen, type IX, alpha 3 |
|
affects expression |
ISO |
3 |
169,704,893 |
169,712,492 |
RGD:6480464 |
CTD |
| G |
Commd8 |
COMM domain containing 8 |
|
affects expression |
ISO |
14 |
38,498,899 |
38,509,474 |
RGD:6480464 |
CTD |
| G |
Comt |
catechol-O-methyltransferase |
|
decreases expression |
ISO |
11 |
84,561,591 |
84,581,713 |
RGD:6480464 |
CTD |
| G |
Copb2 |
coatomer protein complex, subunit beta 2 (beta prime) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cops5 |
COP9 signalosome subunit 5 |
|
affects expression |
ISO |
5 |
8,709,214 |
8,727,277 |
RGD:6480464 |
CTD |
| G |
Cops8 |
COP9 signalosome subunit 8 |
|
affects expression |
ISO |
9 |
89,802,461 |
89,812,293 |
RGD:6480464 |
CTD |
| G |
Coq5 |
coenzyme Q5 homolog, methyltransferase (S. cerevisiae) |
|
affects expression |
ISO |
12 |
42,585,095 |
42,602,004 |
RGD:6480464 |
CTD |
| G |
Coro2a |
coronin, actin binding protein 2A |
|
affects expression |
ISO |
5 |
63,121,905 |
63,152,843 |
RGD:6480464 |
CTD |
| G |
Cox5b |
cytochrome c oxidase subunit Vb |
|
multiple interactions |
ISO |
9 |
35,625,478 |
35,627,304 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
multiple interactions |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
decreases expression |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
increases degradation |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
decreases expression |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpeb3 |
cytoplasmic polyadenylation element binding protein 3 |
|
affects expression |
ISO |
1 |
241,298,277 |
241,444,908 |
RGD:6480464 |
CTD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
affects expression |
ISO |
9 |
65,907,211 |
66,017,942 |
RGD:6480464 |
CTD |
| G |
Cpsf2 |
cleavage and polyadenylation specific factor 2, 100kDa |
|
affects expression |
ISO |
6 |
126,246,237 |
126,274,144 |
RGD:6480464 |
CTD |
| G |
Creb3l3 |
cAMP responsive element binding protein 3-like 3 |
|
affects expression |
ISO |
7 |
10,106,525 |
10,114,960 |
RGD:6480464 |
CTD |
| G |
Creb3l4 |
cAMP responsive element binding protein 3-like 4 |
|
affects expression |
ISO |
2 |
182,477,247 |
182,482,238 |
RGD:6480464 |
CTD |
| G |
Crebrf |
CREB3 regulatory factor |
|
affects expression |
ISO |
10 |
16,665,420 |
16,723,929 |
RGD:6480464 |
CTD |
| G |
Crsp9 |
cofactor required for Sp1 transcriptional activation, subunit 9 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cryl1 |
crystallin, lambda 1 |
|
affects expression |
ISO |
15 |
36,320,075 |
36,440,579 |
RGD:6480464 |
CTD |
| G |
Cux1 |
cut-like homeobox 1 |
|
decreases expression |
ISO |
12 |
21,223,919 |
21,516,938 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
increases expression |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl12 |
chemokine (C-X-C motif) ligand 12 |
|
multiple interactions |
ISO |
4 |
153,503,576 |
153,516,423 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
affects expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
affects expression |
ISO |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyb5a |
cytochrome b5 type A (microsomal) |
|
affects expression |
ISO |
18 |
81,415,972 |
81,452,606 |
RGD:6480464 |
CTD |
| G |
Cyb5b |
cytochrome b5 type B (outer mitochondrial membrane) |
|
affects expression |
ISO |
19 |
37,016,959 |
37,050,722 |
RGD:6480464 |
CTD |
| G |
Cyb5d2 |
cytochrome b5 domain containing 2 |
|
affects expression |
ISO |
10 |
59,667,011 |
59,683,247 |
RGD:6480464 |
CTD |
| G |
Cygb |
cytoglobin |
|
increases metabolic processing |
EXP |
10 |
106,759,885 |
106,769,651 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
affects expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2s1 |
cytochrome P450, family 2, subfamily s, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
81,008,464 |
81,023,486 |
RGD:6480464 |
CTD |
| G |
Cyp2w1 |
cytochrome P450, family 2, subfamily w, polypeptide 1 |
|
affects expression |
ISO |
12 |
15,792,480 |
15,797,202 |
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
increases expression |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
multiple interactions |
ISO |
4 |
26,752,677 |
26,771,131 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
affects expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:6480464 |
CTD |
| G |
Cytl1 |
cytokine like 1 |
|
decreases expression |
ISO |
14 |
78,349,878 |
78,354,888 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
affects expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dapk1 |
death associated protein kinase 1 |
|
decreases expression |
ISO |
17 |
9,617,607 |
9,779,457 |
RGD:6480464 |
CTD |
| G |
Dars |
aspartyl-tRNA synthetase |
|
affects expression |
ISO |
13 |
41,077,395 |
41,132,513 |
RGD:6480464 |
CTD |
| G |
Dcaf11 |
DDB1 and CUL4 associated factor 11 |
|
affects expression |
ISO |
15 |
33,691,576 |
33,701,328 |
RGD:6480464 |
CTD |
| G |
Dcaf13 |
DDB1 and CUL4 associated factor 13 |
|
affects expression |
ISO |
7 |
74,668,602 |
74,703,968 |
RGD:6480464 |
CTD |
| G |
Dcaf4 |
DDB1 and CUL4 associated factor 4 |
|
affects expression |
ISO |
6 |
107,468,810 |
107,494,910 |
RGD:6480464 |
CTD |
| G |
Dclre1a |
DNA cross-link repair 1A |
|
affects expression |
ISO |
1 |
262,822,176 |
262,840,988 |
RGD:6480464 |
CTD |
| G |
Dctn3 |
dynactin 3 |
|
affects expression |
ISO |
5 |
59,139,424 |
59,147,420 |
RGD:6480464 |
CTD |
| G |
Dctpp1 |
dCTP pyrophosphatase 1 |
|
affects expression |
ISO |
1 |
186,519,955 |
186,523,348 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
affects expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
affects expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddr2 |
discoidin domain receptor tyrosine kinase 2 |
|
decreases expression |
ISO |
13 |
85,801,449 |
85,846,636 |
RGD:6480464 |
CTD |
| G |
Ddx1 |
DEAD (Asp-Glu-Ala-Asp) box helicase 1 |
|
affects expression |
ISO |
6 |
36,794,602 |
36,825,473 |
RGD:6480464 |
CTD |
| G |
Ddx10 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 10 |
|
affects expression |
ISO |
8 |
56,557,483 |
56,706,523 |
RGD:6480464 |
CTD |
| G |
Ddx20 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
|
affects expression |
ISO |
2 |
200,929,985 |
200,937,976 |
RGD:6480464 |
CTD |
| G |
Ddx42 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 |
|
increases expression |
ISO |
10 |
95,612,667 |
95,644,162 |
RGD:6480464 |
CTD |
| G |
Ddx5 |
DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
|
affects expression |
ISO |
10 |
96,131,888 |
96,139,423 |
RGD:6480464 |
CTD |
| G |
Ddx50 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 50 |
|
affects expression |
ISO |
20 |
29,867,955 |
29,897,253 |
RGD:6480464 |
CTD |
| G |
Ddx56 |
DEAD (Asp-Glu-Ala-Asp) box helicase 56 |
|
affects expression |
ISO |
14 |
86,985,893 |
86,994,552 |
RGD:6480464 |
CTD |
| G |
Def6 |
differentially expressed in FDCP 6 homolog (mouse) |
|
affects expression |
ISO |
20 |
6,391,694 |
6,469,830 |
RGD:6480464 |
CTD |
| G |
Def8 |
differentially expressed in FDCP 8 homolog (mouse) |
|
affects expression |
ISO |
19 |
53,765,017 |
53,781,294 |
RGD:6480464 |
CTD |
| G |
Defb1 |
defensin beta 1 |
|
affects expression |
ISO |
16 |
74,980,054 |
74,995,445 |
RGD:6480464 |
CTD |
| G |
Depdc7 |
DEP domain containing 7 |
|
affects expression |
ISO |
3 |
90,054,620 |
90,075,902 |
RGD:6480464 |
CTD |
| G |
Det1 |
de-etiolated homolog 1 (Arabidopsis) |
|
affects expression |
ISO |
1 |
134,552,235 |
134,566,070 |
RGD:6480464 |
CTD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
multiple interactions |
ISO |
1 |
204,245,562 |
204,258,913 |
RGD:6480464 |
CTD |
| G |
Dhdh |
dihydrodiol dehydrogenase (dimeric) |
|
affects expression |
ISO |
1 |
95,947,679 |
95,957,869 |
RGD:6480464 |
CTD |
| G |
Dhrs2 |
dehydrogenase/reductase (SDR family) member 2 |
|
affects expression |
ISO |
15 |
33,286,599 |
33,337,467 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
affects expression |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Dhx15 |
DEAH (Asp-Glu-Ala-His) box polypeptide 15 |
|
affects expression |
ISO |
14 |
63,563,251 |
63,601,200 |
RGD:6480464 |
CTD |
| G |
Dhx9 |
DEAH (Asp-Glu-Ala-His) box polypeptide 9 |
|
affects expression |
ISO |
13 |
68,471,256 |
68,507,999 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
multiple interactions |
EXP |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
increases secretion |
EXP |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Diexf |
digestive organ expansion factor homolog (zebrafish) |
|
affects expression |
ISO |
13 |
108,945,112 |
108,966,381 |
RGD:6480464 |
CTD |
| G |
Dimt1 |
DIM1 dimethyladenosine transferase 1 homolog (S. cerevisiae) |
|
affects expression |
ISO |
2 |
38,054,640 |
38,078,326 |
RGD:6480464 |
CTD |
| G |
Dio2 |
deiodinase, iodothyronine, type II |
|
multiple interactions |
EXP |
6 |
114,307,758 |
114,317,563 |
RGD:6480464 |
CTD |
| G |
Dio3 |
deiodinase, iodothyronine, type III |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dio3 |
deiodinase, iodothyronine, type III |
|
increases activity |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dio3 |
deiodinase, iodothyronine, type III |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
increases expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
affects expression |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dld |
dihydrolipoamide dehydrogenase |
|
multiple interactions |
EXP |
6 |
49,185,188 |
49,205,894 |
RGD:6480464 |
CTD |
| G |
Dlx4 |
distal-less homeobox 4 |
|
affects expression |
ISO |
10 |
83,822,815 |
83,828,210 |
RGD:6480464 |
CTD |
| G |
Dnaja1 |
DnaJ (Hsp40) homolog, subfamily A, member 1 |
|
affects expression |
ISO |
5 |
58,100,794 |
58,111,705 |
RGD:6480464 |
CTD |
| G |
Dnajb1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
decreases response to substance |
ISO |
19 |
26,213,739 |
26,217,480 |
RGD:6480464 |
CTD |
| G |
Dnajc22 |
DnaJ (Hsp40) homolog, subfamily C, member 22 |
|
affects expression |
ISO |
7 |
137,875,669 |
137,880,647 |
RGD:6480464 |
CTD |
| G |
Dnajc7 |
DnaJ (Hsp40) homolog, subfamily C, member 7 |
|
affects expression |
ISO |
10 |
89,527,163 |
89,563,723 |
RGD:6480464 |
CTD |
| G |
Dnhd1 |
dynein heavy chain domain 1 |
|
affects expression |
ISO |
1 |
163,380,065 |
163,467,261 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases response to substance |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
decreases response to substance |
EXP |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
decreases response to substance |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnmt3l |
DNA (cytosine-5-)-methyltransferase 3-like |
|
affects expression |
ISO |
20 |
10,958,957 |
10,973,422 |
RGD:6480464 |
CTD |
| G |
Dolk |
dolichol kinase |
|
affects expression |
ISO |
3 |
9,329,640 |
9,331,678 |
RGD:6480464 |
CTD |
| G |
Dopey1 |
dopey family member 1 |
|
affects expression |
ISO |
8 |
91,706,333 |
91,808,911 |
RGD:6480464 |
CTD |
| G |
Dph2 |
DPH2 homolog (S. cerevisiae) |
|
affects expression |
ISO |
5 |
138,354,594 |
138,357,554 |
RGD:6480464 |
CTD |
| G |
Dpm1 |
dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit |
|
affects expression |
ISO |
3 |
159,373,861 |
159,393,404 |
RGD:6480464 |
CTD |
| G |
Dpp3 |
dipeptidylpeptidase 3 |
|
decreases response to substance |
ISO |
3 |
138,286,277 |
138,288,887 |
RGD:6480464 |
CTD |
| G |
Dpys |
dihydropyrimidinase |
|
affects expression |
ISO |
7 |
75,368,238 |
75,446,160 |
RGD:6480464 |
CTD |
| G |
Dpysl3 |
dihydropyrimidinase-like 3 |
|
affects expression |
ISO |
18 |
36,620,669 |
36,680,355 |
RGD:6480464 |
CTD |
| G |
Dr1 |
down-regulator of transcription 1 |
|
affects expression |
ISO |
14 |
2,005,938 |
2,017,291 |
RGD:6480464 |
CTD |
| G |
Dtx3 |
deltex homolog 3 (Drosophila) |
|
affects expression |
ISO |
7 |
67,145,276 |
67,149,937 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
affects expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Edc3 |
enhancer of mRNA decapping 3 homolog (S. cerevisiae) |
|
affects expression |
ISO |
8 |
61,472,266 |
61,517,590 |
RGD:6480464 |
CTD |
| G |
Egr2 |
early growth response 2 |
|
affects expression |
ISO |
20 |
21,883,885 |
21,888,177 |
RGD:6480464 |
CTD |
| G |
Egr4 |
early growth response 4 |
|
affects expression |
ISO |
4 |
119,765,289 |
119,767,612 |
RGD:6480464 |
CTD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
affects expression |
ISO |
4 |
104,016,940 |
104,078,261 |
RGD:6480464 |
CTD |
| G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
|
affects expression |
ISO |
11 |
79,950,592 |
79,957,185 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
affects expression |
ISO |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
Elf2 |
E74-like factor 2 |
|
affects expression |
ISO |
2 |
140,144,023 |
140,221,693 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
decreases expression |
ISO |
X |
12,597,863 |
12,604,248 |
RGD:6480464 |
CTD |
| G |
Ell2 |
elongation factor RNA polymerase II 2 |
|
affects expression |
ISO |
2 |
2,724,984 |
2,794,397 |
RGD:6480464 |
CTD |
| G |
Eml6 |
echinoderm microtubule associated protein like 6 |
|
increases expression |
ISO |
14 |
110,774,217 |
110,979,159 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
affects expression |
ISO |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
affects expression |
ISO |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Endog |
endonuclease G |
|
multiple interactions |
EXP |
3 |
9,184,023 |
9,187,524 |
RGD:6480464 |
CTD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
multiple interactions |
ISO |
6 |
10,203,108 |
10,297,215 |
RGD:6480464 |
CTD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
affects expression |
ISO |
6 |
10,203,108 |
10,297,215 |
RGD:6480464 |
CTD |
| G |
Epas1 |
endothelial PAS domain protein 1 |
|
increases expression |
ISO |
6 |
10,203,108 |
10,297,215 |
RGD:6480464 |
CTD |
| G |
Epb41l1 |
erythrocyte membrane protein band 4.1-like 1 |
|
affects expression |
ISO |
3 |
146,876,451 |
146,944,603 |
RGD:6480464 |
CTD |
| G |
Epc1 |
enhancer of polycomb homolog 1 (Drosophila) |
|
affects expression |
ISO |
17 |
63,040,151 |
63,131,954 |
RGD:6480464 |
CTD |
| G |
Epg5 |
ectopic P-granules autophagy protein 5 homolog (C. elegans) |
|
multiple interactions |
ISO |
18 |
74,846,785 |
74,942,842 |
RGD:6480464 |
CTD |
| G |
Epha2 |
Eph receptor A2 |
|
affects expression |
ISO |
5 |
160,185,143 |
160,214,727 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
increases expression |
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
affects expression |
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:6480464 |
CTD |
| G |
Epn3 |
epsin 3 |
|
affects expression |
ISO |
10 |
83,129,023 |
83,137,401 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
decreases expression |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
decreases expression |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
multiple interactions |
EXP |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Epor |
erythropoietin receptor |
|
affects expression |
ISO |
8 |
21,061,310 |
21,065,886 |
RGD:6480464 |
CTD |
| G |
Eppk1 |
epiplakin 1 |
|
affects expression |
ISO |
7 |
114,135,306 |
114,146,330 |
RGD:6480464 |
CTD |
| G |
Eprs |
glutamyl-prolyl-tRNA synthetase |
|
affects expression |
ISO |
13 |
101,375,656 |
101,448,175 |
RGD:6480464 |
CTD |
| G |
Eps8 |
epidermal growth factor receptor pathway substrate 8 |
|
affects expression |
ISO |
4 |
174,601,291 |
174,672,247 |
RGD:6480464 |
CTD |
| G |
Eps8l2 |
EPS8-like 2 |
|
affects expression |
ISO |
1 |
201,539,214 |
201,560,761 |
RGD:6480464 |
CTD |
| G |
Epsti1 |
epithelial stromal interaction 1 (breast) |
|
affects expression |
ISO |
15 |
58,989,876 |
59,088,931 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
affects expression |
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Erbb2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
|
decreases expression |
ISO |
10 |
87,219,157 |
87,242,919 |
RGD:6480464 |
CTD |
| G |
Ereg |
epiregulin |
|
affects expression |
ISO |
14 |
18,521,069 |
18,534,844 |
RGD:6480464 |
CTD |
| G |
Ethe1 |
ethylmalonic encephalopathy 1 |
|
affects expression |
ISO |
1 |
79,875,629 |
79,890,681 |
RGD:6480464 |
CTD |
| G |
Ets2 |
v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) |
|
affects expression |
ISO |
11 |
36,014,047 |
36,030,833 |
RGD:6480464 |
CTD |
| G |
Ewsr1 |
Ewing sarcoma breakpoint region 1 |
|
affects expression |
ISO |
14 |
85,730,483 |
85,758,958 |
RGD:6480464 |
CTD |
| G |
Exosc3 |
exosome component 3 |
|
affects expression |
ISO |
5 |
61,880,622 |
61,883,825 |
RGD:6480464 |
CTD |
| G |
Exosc4 |
exosome component 4 |
|
affects expression |
ISO |
7 |
114,374,913 |
114,377,655 |
RGD:6480464 |
CTD |
| G |
Exosc9 |
exosome component 9 |
|
affects expression |
ISO |
2 |
123,051,592 |
123,062,494 |
RGD:6480464 |
CTD |
| G |
Ezh2 |
enhancer of zeste homolog 2 (Drosophila) |
|
affects expression |
ISO |
4 |
75,709,959 |
75,773,279 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
affects expression |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
F11r |
F11 receptor |
|
affects expression |
ISO |
13 |
87,369,918 |
87,393,508 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
affects expression |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F2r |
coagulation factor II (thrombin) receptor |
|
increases expression |
ISO |
2 |
25,985,800 |
25,989,072 |
RGD:6480464 |
CTD |
| G |
F7 |
coagulation factor VII (serum prothrombin conversion accelerator) |
|
affects expression |
ISO |
16 |
81,348,678 |
81,358,991 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
affects expression |
ISO |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fam105a |
family with sequence similarity 105, member A |
|
affects expression |
ISO |
2 |
79,545,446 |
79,569,132 |
RGD:6480464 |
CTD |
| G |
Fam117a |
family with sequence similarity 117, member A |
|
affects expression |
ISO |
10 |
84,022,262 |
84,067,048 |
RGD:6480464 |
CTD |
| G |
Fam118b |
family with sequence similarity 118, member B |
|
affects expression |
ISO |
8 |
34,998,500 |
35,020,233 |
RGD:6480464 |
CTD |
| G |
Fam151a |
family with sequence similarity 151, member A |
|
affects expression |
ISO |
5 |
127,809,098 |
127,821,849 |
RGD:6480464 |
CTD |
| G |
Fam160a2 |
family with sequence similarity 160, member A2 |
|
affects expression |
ISO |
1 |
163,110,927 |
163,133,590 |
RGD:6480464 |
CTD |
| G |
Fam173b |
family with sequence similarity 173, member B |
|
affects expression |
ISO |
2 |
83,693,155 |
83,708,195 |
RGD:6480464 |
CTD |
| G |
Fam208a |
family with sequence similarity 208, member A |
|
increases expression |
ISO |
16 |
2,691,237 |
2,747,457 |
RGD:6480464 |
CTD |
| G |
Fam46a |
family with sequence similarity 46, member A |
|
affects expression |
ISO |
8 |
90,502,441 |
90,506,129 |
RGD:6480464 |
CTD |
| G |
Fam46c |
family with sequence similarity 46, member C |
|
affects expression |
ISO |
2 |
195,462,849 |
195,481,953 |
RGD:6480464 |
CTD |
| G |
Fam63a |
family with sequence similarity 63, member A |
|
affects expression |
ISO |
2 |
190,198,815 |
190,206,098 |
RGD:6480464 |
CTD |
| G |
Fance |
Fanconi anemia, complementation group E |
|
affects expression |
ISO |
20 |
6,549,701 |
6,566,916 |
RGD:6480464 |
CTD |
| G |
Farsb |
phenylalanyl-tRNA synthetase, beta subunit |
|
affects expression |
ISO |
9 |
77,806,573 |
77,865,757 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
decreases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
ISO |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases chemical synthesis |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fastkd1 |
FAST kinase domains 1 |
|
affects expression |
ISO |
3 |
51,831,438 |
51,857,646 |
RGD:6480464 |
CTD |
| G |
Fbln1 |
fibulin 1 |
|
affects expression |
ISO |
7 |
123,208,154 |
123,287,289 |
RGD:6480464 |
CTD |
| G |
Fbxl15 |
F-box and leucine-rich repeat protein 15 |
|
affects expression |
ISO |
1 |
251,544,341 |
251,546,582 |
RGD:6480464 |
CTD |
| G |
Fbxl16 |
F-box and leucine-rich repeat protein 16 |
|
affects expression |
ISO |
10 |
15,082,199 |
15,085,374 |
RGD:6480464 |
CTD |
| G |
Fbxl4 |
F-box and leucine-rich repeat protein 4 |
|
affects expression |
ISO |
5 |
37,156,876 |
37,230,228 |
RGD:6480464 |
CTD |
| G |
Fbxo3 |
F-box protein 3 |
|
affects expression |
ISO |
3 |
89,446,724 |
89,479,650 |
RGD:6480464 |
CTD |
| G |
Fbxo30 |
F-box protein 30 |
|
affects expression |
ISO |
1 |
5,975,207 |
5,991,214 |
RGD:6480464 |
CTD |
| G |
Fbxo9 |
f-box protein 9 |
|
affects expression |
ISO |
8 |
83,056,071 |
83,081,992 |
RGD:6480464 |
CTD |
| G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
|
multiple interactions |
ISO |
15 |
42,425,336 |
42,453,390 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
multiple interactions |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fdx1 |
ferredoxin 1 |
|
increases expression |
ISO |
8 |
55,291,396 |
55,310,507 |
RGD:6480464 |
CTD |
| G |
Fdxr |
ferredoxin reductase |
|
increases expression |
ISO |
10 |
105,342,684 |
105,351,374 |
RGD:6480464 |
CTD |
| G |
Fech |
ferrochelatase |
|
decreases expression |
ISO |
18 |
60,675,217 |
60,708,418 |
RGD:6480464 |
CTD |
| G |
Fen1 |
flap structure-specific endonuclease 1 |
|
decreases expression |
ISO |
1 |
212,688,118 |
212,692,486 |
RGD:6480464 |
CTD |
| G |
Fer1l4 |
fer-1-like 4 (C. elegans) |
|
affects expression |
ISO |
3 |
146,427,611 |
146,463,147 |
RGD:6480464 |
CTD |
| G |
Fgd3 |
FYVE, RhoGEF and PH domain containing 3 |
|
affects expression |
ISO |
17 |
21,292,539 |
21,343,264 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
decreases response to substance |
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf7 |
fibroblast growth factor 7 |
|
decreases response to substance |
ISO |
3 |
113,468,427 |
113,517,538 |
RGD:6480464 |
CTD |
| G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
|
affects expression |
ISO |
14 |
72,242,271 |
72,243,353 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
multiple interactions |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
decreases expression |
ISO |
16 |
70,869,974 |
70,910,045 |
RGD:6480464 |
CTD |
| G |
Fgfr1op |
Fgfr1 oncogene partner |
|
affects expression |
ISO |
1 |
47,176,365 |
47,205,468 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
affects expression |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
decreases expression |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
multiple interactions |
ISO |
1 |
189,482,975 |
189,589,279 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
affects expression |
ISO |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
Fgg |
fibrinogen gamma chain |
|
increases expression |
ISO |
2 |
174,727,312 |
174,734,594 |
RGD:6480464 |
CTD |
| G |
Fh |
fumarate hydratase |
|
affects expression |
ISO |
13 |
91,329,837 |
91,355,722 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
affects expression |
ISO |
9 |
42,319,997 |
42,349,055 |
RGD:6480464 |
CTD |
| G |
Fignl1 |
fidgetin-like 1 |
|
affects expression |
ISO |
14 |
92,685,445 |
92,693,967 |
RGD:6480464 |
CTD |
| G |
Fjx1 |
four jointed box 1 (Drosophila) |
|
affects expression |
ISO |
3 |
87,640,138 |
87,642,239 |
RGD:6480464 |
CTD |
| G |
Fkbp1a |
FK506 binding protein 1a |
|
increases expression |
EXP |
3 |
141,861,237 |
141,880,797 |
RGD:6480464 |
CTD |
| G |
Flcn |
folliculin |
|
affects expression |
ISO |
10 |
46,110,527 |
46,129,613 |
RGD:6480464 |
CTD |
| G |
Flrt3 |
fibronectin leucine rich transmembrane protein 3 |
|
affects expression |
ISO |
3 |
128,922,726 |
128,934,866 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
ISO |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmod |
fibromodulin |
|
affects expression |
ISO |
13 |
46,987,714 |
46,998,331 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
multiple interactions |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases expression |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
increases secretion |
ISO |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Foxc1 |
forkhead box C1 |
|
affects expression |
ISO |
17 |
39,026,186 |
39,030,163 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
increases expression |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
increases degradation |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
multiple interactions |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Ftmt |
ferritin mitochondrial |
|
increases expression |
ISO |
18 |
47,678,332 |
47,679,581 |
RGD:6480464 |
CTD |
| G |
Fut1 |
fucosyltransferase 1 |
|
affects expression |
ISO |
1 |
96,085,914 |
96,089,332 |
RGD:6480464 |
CTD |
| G |
Fxyd5 |
FXYD domain-containing ion transport regulator 5 |
|
increases expression |
ISO |
1 |
86,076,279 |
86,085,681 |
RGD:6480464 |
CTD |
| G |
Fyttd1 |
forty-two-three domain containing 1 |
|
affects expression |
ISO |
11 |
69,700,526 |
69,720,622 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
affects expression |
ISO |
10 |
91,709,222 |
91,711,132 |
RGD:6480464 |
CTD |
| G |
Fzd4 |
frizzled family receptor 4 |
|
affects expression |
ISO |
1 |
145,953,743 |
145,957,666 |
RGD:6480464 |
CTD |
| G |
Fzd5 |
frizzled family receptor 5 |
|
affects expression |
ISO |
9 |
63,386,990 |
63,388,747 |
RGD:6480464 |
CTD |
| G |
Fzd6 |
frizzled family receptor 6 |
|
affects expression |
ISO |
7 |
74,562,307 |
74,594,014 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
affects expression |
ISO |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
G3bp2 |
GTPase activating protein (SH3 domain) binding protein 2 |
|
affects expression |
ISO |
14 |
17,556,967 |
17,588,259 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases activity |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
increases activity |
ISO |
X |
160,186,450 |
160,192,316 |
RGD:6480464 |
CTD |
| G |
Gaa |
glucosidase, alpha, acid |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gab2 |
GRB2-associated binding protein 2 |
|
affects expression |
ISO |
1 |
154,348,777 |
154,544,906 |
RGD:6480464 |
CTD |
| G |
Gabarapl1 |
GABA(A) receptor-associated protein like 1 |
|
affects expression |
ISO |
4 |
166,802,106 |
166,811,249 |
RGD:6480464 |
CTD |
| G |
Gabpb2 |
GA binding protein transcription factor, beta subunit 2 |
|
affects expression |
ISO |
2 |
190,094,254 |
190,114,114 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
decreases response to substance |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gad1 |
glutamate decarboxylase 1 |
|
affects expression |
ISO |
3 |
52,789,370 |
52,830,038 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin/GMAP prepropeptide |
|
affects expression |
ISO |
1 |
205,936,352 |
205,941,215 |
RGD:6480464 |
CTD |
| G |
Gal3st1 |
galactose-3-O-sulfotransferase 1 |
|
affects expression |
ISO |
14 |
84,636,490 |
84,642,269 |
RGD:6480464 |
CTD |
| G |
Galm |
galactose mutarotase (aldose 1-epimerase) |
|
affects expression |
ISO |
6 |
3,024,123 |
3,078,720 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
increases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
decreases expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
affects expression |
ISO |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Garnl3 |
GTPase activating Rap/RanGAP domain-like 3 |
|
affects expression |
ISO |
3 |
11,976,369 |
12,076,318 |
RGD:6480464 |
CTD |
| G |
Gart |
phosphoribosylglycinamide formyltransferase |
|
affects expression |
ISO |
11 |
31,594,859 |
31,620,110 |
RGD:6480464 |
CTD |
| G |
Gas2l1 |
growth arrest-specific 2 like 1 |
|
affects expression |
ISO |
14 |
85,716,617 |
85,726,368 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
multiple interactions |
EXP |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gata3 |
GATA binding protein 3 |
|
affects expression |
ISO |
17 |
79,991,587 |
80,011,574 |
RGD:6480464 |
CTD |
| G |
Gatm |
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
|
affects expression |
ISO |
3 |
109,558,043 |
109,565,432 |
RGD:6480464 |
CTD |
| G |
Gchfr |
GTP cyclohydrolase I feedback regulator |
|
affects expression |
ISO |
3 |
105,683,288 |
105,687,349 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
affects expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
increases expression |
ISO |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
|
affects expression |
ISO |
1 |
220,824,976 |
220,829,980 |
RGD:6480464 |
CTD |
| G |
Gcnt3 |
glucosaminyl (N-acetyl) transferase 3, mucin type |
|
affects expression |
ISO |
8 |
74,470,610 |
74,474,086 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
affects expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
decreases expression |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
multiple interactions |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
|
affects expression |
ISO |
1 |
156,703,241 |
156,794,530 |
RGD:6480464 |
CTD |
| G |
Gemin5 |
gem (nuclear organelle) associated protein 5 |
|
affects expression |
ISO |
10 |
43,754,719 |
43,796,361 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfer |
growth factor, augmenter of liver regeneration |
|
affects response to substance |
ISO |
10 |
13,946,311 |
13,948,665 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases response to substance |
ISO |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gins3 |
GINS complex subunit 3 (Psf3 homolog) |
|
affects expression |
ISO |
19 |
9,876,690 |
9,885,226 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases phosphorylation |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
multiple interactions |
EXP |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Glb1 |
galactosidase, beta 1 |
|
affects expression |
ISO |
8 |
118,791,550 |
118,864,281 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin (thioltransferase) |
|
increases expression |
ISO |
2 |
2,888,605 |
2,899,216 |
RGD:6480464 |
CTD |
| G |
Gls |
glutaminase |
|
affects expression |
ISO |
9 |
46,380,165 |
46,452,974 |
RGD:6480464 |
CTD |
| G |
Glt8d1 |
glycosyltransferase 8 domain containing 1 |
|
affects expression |
ISO |
16 |
6,429,357 |
6,444,262 |
RGD:6480464 |
CTD |
| G |
Glyctk |
glycerate kinase |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS complex locus |
|
decreases expression |
ISO |
3 |
165,213,399 |
165,214,551 |
RGD:6480464 |
CTD |
| G |
Gnaz |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
affects expression |
ISO |
20 |
14,148,003 |
14,174,136 |
RGD:6480464 |
CTD |
| G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
decreases expression |
ISO |
5 |
172,341,135 |
172,386,772 |
RGD:6480464 |
CTD |
| G |
Gnb2 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 |
|
decreases expression |
ISO |
12 |
19,597,312 |
19,602,329 |
RGD:6480464 |
CTD |
| G |
Gne |
glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase |
|
affects expression |
ISO |
5 |
60,506,171 |
60,536,403 |
RGD:6480464 |
CTD |
| G |
Gnl2 |
guanine nucleotide binding protein-like 2 (nucleolar) |
|
affects expression |
ISO |
5 |
144,373,848 |
144,399,235 |
RGD:6480464 |
CTD |
| G |
Gnl3 |
guanine nucleotide binding protein-like 3 (nucleolar) |
|
affects expression |
ISO |
16 |
6,444,437 |
6,450,375 |
RGD:6480464 |
CTD |
| G |
Gnrh1 |
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) |
|
affects expression |
ISO |
15 |
47,303,309 |
47,307,517 |
RGD:6480464 |
CTD |
| G |
Gpank1 |
G patch domain and ankyrin repeats 1 |
|
affects expression |
ISO |
20 |
3,761,295 |
3,764,338 |
RGD:6480464 |
CTD |
| G |
Gpatc2 |
G patch domain containing 2 |
|
affects expression |
ISO |
13 |
103,353,994 |
103,371,422 |
RGD:6480464 |
CTD |
| G |
Gpatch4 |
G patch domain containing 4 |
|
affects expression |
ISO |
2 |
180,123,437 |
180,132,225 |
RGD:6480464 |
CTD |
| G |
Gpatch8 |
G patch domain containing 8 |
|
multiple interactions |
ISO |
10 |
91,580,259 |
91,660,338 |
RGD:6480464 |
CTD |
| G |
Gpkow |
G patch domain and KOW motifs |
|
affects expression |
ISO |
X |
26,832,382 |
26,846,629 |
RGD:6480464 |
CTD |
| G |
Gpn3 |
GPN-loop GTPase 3 |
|
affects expression |
ISO |
12 |
35,384,028 |
35,392,646 |
RGD:6480464 |
CTD |
| G |
Gprc5a |
G protein-coupled receptor, family C, group 5, member A |
|
affects expression |
ISO |
4 |
171,987,364 |
172,006,276 |
RGD:6480464 |
CTD |
| G |
Gprin3 |
GPRIN family member 3 |
|
increases expression |
ISO |
4 |
88,376,454 |
88,378,742 |
RGD:6480464 |
CTD |
| G |
Gpt2 |
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
|
affects expression |
ISO |
19 |
22,884,586 |
22,915,553 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
affects abundance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases reduction |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
increases metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases reduction |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
affects expression |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx2 |
glutathione peroxidase 2 |
|
increases expression |
ISO |
6 |
99,372,418 |
99,376,230 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
ISO |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases response to substance |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
increases response to substance |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases response to substance |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gpx4 |
glutathione peroxidase 4 |
|
decreases response to substance |
ISO |
7 |
11,162,521 |
11,165,318 |
RGD:6480464 |
CTD |
| G |
Gpx5 |
glutathione peroxidase 5 |
|
affects metabolic processing |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Grin2c |
glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
affects expression |
ISO |
10 |
105,323,371 |
105,340,976 |
RGD:6480464 |
CTD |
| G |
Grin2c |
glutamate receptor, ionotropic, N-methyl D-aspartate 2C |
|
increases expression |
ISO |
10 |
105,323,371 |
105,340,976 |
RGD:6480464 |
CTD |
| G |
Grk5 |
G protein-coupled receptor kinase 5 |
|
affects expression |
ISO |
1 |
267,495,534 |
267,693,144 |
RGD:6480464 |
CTD |
| G |
Grpel2 |
GrpE-like 2, mitochondrial |
|
affects expression |
ISO |
18 |
57,691,610 |
57,703,850 |
RGD:6480464 |
CTD |
| G |
Gsn |
gelsolin |
|
affects expression |
ISO |
3 |
14,360,245 |
14,386,313 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
affects expression |
ISO |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
increases expression |
EXP |
9 |
20,051,501 |
20,068,146 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
ISO |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
decreases response to substance |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
affects expression |
ISO |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gsta5 |
glutathione S-transferase alpha 5 |
|
decreases response to substance |
EXP |
8 |
83,202,554 |
83,211,997 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
increases expression |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
decreases response to substance |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
affects localization |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Hccs |
holocytochrome c synthase |
|
affects expression |
ISO |
X |
45,617,395 |
45,626,790 |
RGD:6480464 |
CTD |
| G |
Hdac1 |
histone deacetylase 1 |
|
decreases expression |
ISO |
5 |
148,672,515 |
148,699,810 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
multiple interactions |
ISO |
20 |
41,162,093 |
41,186,492 |
RGD:6480464 |
CTD |
| G |
Hdac2 |
histone deacetylase 2 |
|
decreases activity |
ISO |
20 |
41,162,093 |
41,186,492 |
RGD:6480464 |
CTD |
| G |
Hdac6 |
histone deacetylase 6 |
|
affects expression |
ISO |
X |
26,585,852 |
26,606,999 |
RGD:6480464 |
CTD |
| G |
Heatr1 |
HEAT repeat containing 1 |
|
affects expression |
ISO |
17 |
68,613,162 |
68,654,896 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
affects expression |
ISO |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Hes1 |
hairy and enhancer of split 1 (Drosophila) |
|
affects expression |
ISO |
11 |
72,603,482 |
72,605,673 |
RGD:6480464 |
CTD |
| G |
Heyl |
hairy/enhancer-of-split related with YRPW motif-like |
|
affects expression |
ISO |
5 |
142,544,185 |
142,561,176 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
decreases expression |
ISO |
4 |
14,864,357 |
14,932,513 |
RGD:6480464 |
CTD |
| G |
Hgfac |
HGF activator |
|
decreases expression |
ISO |
14 |
81,348,282 |
81,354,836 |
RGD:6480464 |
CTD |
| G |
Hhat |
hedgehog acyltransferase |
|
affects expression |
ISO |
13 |
108,411,459 |
108,651,307 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
|
multiple interactions |
ISO |
1 |
77,377,465 |
77,408,704 |
RGD:6480464 |
CTD |
| G |
Hif3a |
hypoxia inducible factor 3, alpha subunit |
|
increases expression |
ISO |
1 |
77,377,465 |
77,408,704 |
RGD:6480464 |
CTD |
| G |
Hint1 |
histidine triad nucleotide binding protein 1 |
|
decreases expression |
ISO |
10 |
40,271,895 |
40,275,640 |
RGD:6480464 |
CTD |
| G |
Hint3 |
histidine triad nucleotide binding protein 3 |
|
affects expression |
ISO |
1 |
27,719,396 |
27,729,255 |
RGD:6480464 |
CTD |
| G |
Hist1h2bb |
histone cluster 1, H2bb |
|
affects expression |
ISO |
17 |
48,512,993 |
48,513,373 |
RGD:6480464 |
CTD |
| G |
Hist2h2aa3 |
histone cluster 2, H2aa3 |
|
affects expression |
ISO |
2 |
191,052,007 |
191,052,604 |
RGD:6480464 |
CTD |
| G |
Hist3h2bb |
histone cluster 3, H2bb |
|
affects expression |
ISO |
10 |
45,244,935 |
45,245,682 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
multiple interactions |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hist3h3 |
histone cluster 3, H3 |
|
decreases acetylation |
ISO |
10 |
45,252,993 |
45,253,403 |
RGD:6480464 |
CTD |
| G |
Hk2 |
hexokinase 2 |
|
affects expression |
ISO |
4 |
116,925,725 |
116,975,211 |
RGD:6480464 |
CTD |
| G |
Hlcs |
holocarboxylase synthetase (biotin-(proprionyl-CoA-carboxylase (ATP-hydrolysing)) ligase) |
|
affects expression |
ISO |
11 |
34,382,010 |
34,539,032 |
RGD:6480464 |
CTD |
| G |
Hmga1 |
high mobility group AT-hook 1 |
|
decreases expression |
ISO |
20 |
5,769,052 |
5,772,269 |
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
affects localization |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgb1 |
high mobility group box 1 |
|
increases secretion |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases expression |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
ISO |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
multiple interactions |
ISO |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
affects expression |
ISO |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
|
increases expression |
EXP |
2 |
51,737,090 |
51,754,583 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox2 |
heme oxygenase (decycling) 2 |
|
decreases response to substance |
ISO |
10 |
10,914,157 |
10,929,448 |
RGD:6480464 |
CTD |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
multiple interactions |
ISO |
3 |
154,459,863 |
154,482,825 |
RGD:6480464 |
CTD |
| G |
Hnrnpab |
heterogeneous nuclear ribonucleoprotein A/B |
|
affects expression |
ISO |
10 |
37,117,285 |
37,123,177 |
RGD:6480464 |
CTD |
| G |
Hnrnpc |
heterogeneous nuclear ribonucleoprotein C (C1/C2) |
|
multiple interactions |
ISO |
15 |
27,516,839 |
27,546,646 |
RGD:6480464 |
CTD |
| G |
Hnrpd |
heterogeneous nuclear ribonucleoprotein D |
|
affects expression |
ISO |
14 |
10,917,674 |
10,935,989 |
RGD:6480464 |
CTD |
| G |
Homer1 |
homer homolog 1 (Drosophila) |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hoxa1 |
homeo box A1 |
|
affects expression |
ISO |
4 |
80,456,728 |
80,458,388 |
RGD:6480464 |
CTD |
| G |
Hoxa4 |
homeo box A4 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hoxa7 |
homeobox A7 |
|
affects expression |
ISO |
4 |
80,515,622 |
80,517,521 |
RGD:6480464 |
CTD |
| G |
Hoxb6 |
homeo box B6 |
|
affects expression |
ISO |
10 |
85,030,558 |
85,033,604 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
affects expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
increases expression |
ISO |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
|
affects expression |
ISO |
14 |
6,859,573 |
6,891,511 |
RGD:6480464 |
CTD |
| G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
|
affects expression |
ISO |
19 |
47,729,519 |
47,802,933 |
RGD:6480464 |
CTD |
| G |
Hspa14 |
heat shock protein 14 |
|
affects expression |
ISO |
17 |
85,848,593 |
85,869,375 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects localization |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects localization |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
ISO |
20 |
3,955,274 |
3,957,748 |
RGD:6480464 |
CTD |
| G |
Hspa2 |
heat shock protein 2 |
|
affects expression |
ISO |
6 |
99,000,541 |
99,003,041 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases phosphorylation |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspb8 |
heat shock protein B8 |
|
increases expression |
ISO |
12 |
41,407,166 |
41,421,565 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
affects expression |
ISO |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Htatip2 |
HIV-1 Tat interactive protein 2 |
|
affects expression |
ISO |
1 |
99,563,187 |
99,577,802 |
RGD:6480464 |
CTD |
| G |
Htatsf1 |
HIV-1 Tat specific factor 1 |
|
affects expression |
ISO |
X |
141,697,471 |
141,711,652 |
RGD:6480464 |
CTD |
| G |
Hyal3 |
hyaluronoglucosaminidase 3 |
|
affects expression |
ISO |
8 |
112,828,150 |
112,833,785 |
RGD:6480464 |
CTD |
| G |
Hypk |
Huntingtin interacting protein K |
|
affects expression |
ISO |
3 |
108,262,767 |
108,264,495 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
affects expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
affects expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id1 |
inhibitor of DNA binding 1 |
|
decreases expression |
ISO |
3 |
143,086,162 |
143,087,289 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
affects expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id3 |
inhibitor of DNA binding 3 |
|
affects expression |
ISO |
5 |
154,934,138 |
154,935,707 |
RGD:6480464 |
CTD |
| G |
Idua |
iduronidase, alpha-L- |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ier2 |
immediate early response 2 |
|
affects expression |
ISO |
19 |
25,159,276 |
25,160,800 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
affects expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ier5 |
immediate early response 5 |
|
affects expression |
ISO |
13 |
70,058,818 |
70,060,910 |
RGD:6480464 |
CTD |
| G |
Ifi27 |
interferon, alpha-inducible protein 27 |
|
affects expression |
ISO |
6 |
127,725,194 |
127,731,665 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
affects expression |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Ifitm1 |
interferon induced transmembrane protein 1 |
|
affects expression |
ISO |
1 |
201,154,494 |
201,155,509 |
RGD:6480464 |
CTD |
| G |
Ifitm3 |
interferon induced transmembrane protein 3 |
|
increases expression |
ISO |
1 |
201,198,659 |
201,199,768 |
RGD:6480464 |
CTD |
| G |
Ifnb1 |
interferon beta 1, fibroblast |
|
increases expression |
ISO |
5 |
107,837,628 |
107,838,182 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
affects expression |
ISO |
1 |
14,846,369 |
14,864,804 |
RGD:6480464 |
CTD |
| G |
Ifrd1 |
interferon-related developmental regulator 1 |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
decreases response to substance |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
multiple interactions |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
increases expression |
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:6480464 |
CTD |
| G |
Igflr1 |
IGF-like family receptor 1 |
|
affects expression |
ISO |
1 |
85,611,299 |
85,613,177 |
RGD:6480464 |
CTD |
| G |
Ik |
IK cytokine, down-regulator of HLA II |
|
affects expression |
ISO |
18 |
29,444,004 |
29,458,808 |
RGD:6480464 |
CTD |
| G |
Ikbkb |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
affects response to substance |
ISO |
16 |
73,804,730 |
73,858,510 |
RGD:6480464 |
CTD |
| G |
Ikbke |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon |
|
affects expression |
ISO |
13 |
44,197,625 |
44,222,609 |
RGD:6480464 |
CTD |
| G |
Impad1 |
inositol monophosphatase domain containing 1 |
|
affects expression |
ISO |
5 |
18,086,121 |
18,109,691 |
RGD:6480464 |
CTD |
| G |
Ing5 |
inhibitor of growth family, member 5 |
|
affects expression |
ISO |
9 |
93,076,701 |
93,094,002 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
increases expression |
ISO |
13 |
32,170,987 |
32,176,689 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
multiple interactions |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Ints10 |
integrator complex subunit 10 |
|
affects expression |
ISO |
16 |
21,907,203 |
21,938,144 |
RGD:6480464 |
CTD |
| G |
Ints2 |
integrator complex subunit 2 |
|
affects expression |
ISO |
10 |
74,462,429 |
74,485,977 |
RGD:6480464 |
CTD |
| G |
Ipo4 |
importin 4 |
|
affects expression |
ISO |
15 |
33,761,275 |
33,771,195 |
RGD:6480464 |
CTD |
| G |
Ipo5 |
importin 5 |
|
affects expression |
ISO |
15 |
105,944,155 |
106,021,407 |
RGD:6480464 |
CTD |
| G |
Ipo7 |
importin 7 |
|
affects expression |
ISO |
1 |
167,658,312 |
167,698,113 |
RGD:6480464 |
CTD |
| G |
Irak1 |
interleukin-1 receptor-associated kinase 1 |
|
affects expression |
ISO |
X |
159,960,184 |
159,969,180 |
RGD:6480464 |
CTD |
| G |
Irf5 |
interferon regulatory factor 5 |
|
affects expression |
ISO |
4 |
56,407,560 |
56,418,694 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
decreases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itga5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
|
decreases expression |
ISO |
7 |
142,254,256 |
142,277,464 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
affects expression |
ISO |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itga7 |
integrin, alpha 7 |
|
decreases expression |
ISO |
7 |
2,230,747 |
2,269,403 |
RGD:6480464 |
CTD |
| G |
Itgal |
integrin, alpha L |
|
decreases expression |
ISO |
1 |
186,561,795 |
186,598,908 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
multiple interactions |
ISO |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgav |
integrin, alpha V |
|
decreases expression |
ISO |
3 |
66,953,403 |
67,029,774 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
affects expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
decreases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb4 |
integrin, beta 4 |
|
decreases expression |
ISO |
10 |
106,080,452 |
106,116,632 |
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb6 |
integrin, beta 6 |
|
decreases expression |
ISO |
3 |
42,286,140 |
42,360,793 |
RGD:6480464 |
CTD |
| G |
Itln1 |
intelectin 1 (galactofuranose binding) |
|
affects expression |
ISO |
13 |
87,445,119 |
87,455,226 |
RGD:6480464 |
CTD |
| G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
|
affects expression |
ISO |
20 |
5,292,430 |
5,357,502 |
RGD:6480464 |
CTD |
| G |
Kcnq5 |
potassium voltage-gated channel, KQT-like subfamily, member 5 |
|
affects expression |
ISO |
9 |
20,181,402 |
20,767,644 |
RGD:6480464 |
CTD |
| G |
Kdm4b |
lysine (K)-specific demethylase 4B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Kdm5a |
lysine (K)-specific demethylase 5A |
|
affects expression |
ISO |
4 |
156,736,343 |
156,811,991 |
RGD:6480464 |
CTD |
| G |
Klhl5 |
kelch-like family member 5 |
|
affects expression |
ISO |
14 |
45,846,061 |
45,886,040 |
RGD:6480464 |
CTD |
| G |
Lbh |
limb bud and heart development |
|
affects expression |
ISO |
6 |
22,662,376 |
22,664,667 |
RGD:6480464 |
CTD |
| G |
LOC100151767 |
hypothetical LOC100151767 |
|
affects expression |
ISO |
8 |
53,966,678 |
53,977,137 |
RGD:6480464 |
CTD |
| G |
LOC100360056 |
6.8 kDa mitochondrial proteolipid |
|
decreases expression |
ISO |
1 |
172,267,931 |
172,268,661 |
RGD:6480464 |
CTD |
| G |
LOC100360497 |
G protein-coupled receptor 114-like |
|
increases expression |
ISO |
19 |
10,517,112 |
10,539,070 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
multiple interactions |
EXP |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
increases secretion |
EXP |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
LOC100361295 |
methylmalonyl-Coenzyme A mutase |
|
affects expression |
ISO |
9 |
15,768,911 |
15,797,489 |
RGD:6480464 |
CTD |
| G |
LOC100361913 |
rCG54286-like |
|
affects expression |
ISO |
1 |
84,383,795 |
84,384,760 |
RGD:6480464 |
CTD |
| G |
LOC498222 |
similar to specifically androgen-regulated protein |
|
affects expression |
ISO |
13 |
43,666,569 |
43,679,410 |
RGD:6480464 |
CTD |
| G |
LOC500354 |
similar to C030030A07Rik protein |
|
affects expression |
ISO |
4 |
173,862,352 |
173,874,481 |
RGD:6480464 |
CTD |
| G |
LOC502894 |
hypothetical protein LOC502894 |
|
affects expression |
ISO |
4 |
163,481,393 |
163,502,412 |
RGD:6480464 |
CTD |
| G |
LOC681292 |
hypothetical protein LOC681292 |
|
decreases expression |
ISO |
3 |
120,453,601 |
120,537,113 |
RGD:6480464 |
CTD |
| G |
LOC689959 |
hypothetical protein LOC689959 |
|
affects expression |
ISO |
8 |
54,093,696 |
54,100,678 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases activity |
EXP |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Map3k5 |
mitogen-activated protein kinase kinase kinase 5 |
|
increases expression |
EXP |
1 |
15,205,361 |
15,346,422 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
multiple interactions |
ISO |
10 |
47,649,203 |
47,654,316 |
RGD:6480464 |
CTD |
| G |
Mfsd12 |
major facilitator superfamily domain containing 12 |
|
affects expression |
ISO |
7 |
9,831,853 |
9,838,324 |
RGD:6480464 |
CTD |
| G |
MGC94335 |
similar to hypothetical protein FLJ22555 |
|
affects expression |
ISO |
9 |
56,302,284 |
56,310,215 |
RGD:6480464 |
CTD |
| G |
Mpc2 |
mitochondrial pyruvate carrier 2 |
|
affects expression |
ISO |
13 |
81,184,656 |
81,203,905 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
affects expression |
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
multiple interactions |
ISO |
MT |
7,006 |
7,689 |
RGD:6480464 |
CTD |
| G |
Mt-co2 |
mitochondrially encoded cytochrome c oxidase II |
|
increases expression |
ISO |
MT |
7,006 |
7,689 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
multiple interactions |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
ISO |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mta3 |
metastasis associated 1 family, member 3 |
|
affects expression |
ISO |
6 6 |
7,060,212 7,060,212 |
7,180,405 7,180,405 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal-regulatory transcription factor 1 |
|
multiple interactions |
ISO |
5 |
144,135,674 |
144,180,430 |
RGD:6480464 |
CTD |
| G |
Nat10 |
N-acetyltransferase 10 (GCN5-related) |
|
affects expression |
ISO |
3 |
89,015,613 |
89,054,370 |
RGD:6480464 |
CTD |
| G |
Nav2 |
neuron navigator 2 |
|
affects expression |
ISO |
1 |
99,041,044 |
99,410,077 |
RGD:6480464 |
CTD |
| G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
|
affects expression |
ISO |
2 |
113,069,474 |
113,128,268 |
RGD:6480464 |
CTD |
| G |
Nceh1 |
neutral cholesterol ester hydrolase 1 |
|
affects expression |
ISO |
2 |
113,069,474 |
113,128,268 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases localization |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nmd3 |
NMD3 homolog (S. cerevisiae) |
|
increases expression |
ISO |
2 |
159,851,267 |
159,876,465 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Ntn4 |
netrin 4 |
|
affects expression |
ISO |
7 |
30,717,988 |
30,832,378 |
RGD:6480464 |
CTD |
| G |
Ocel1 |
occludin/ELL domain containing 1 |
|
affects expression |
ISO |
16 |
18,532,477 |
18,534,246 |
RGD:6480464 |
CTD |
| G |
Ociad2 |
OCIA domain containing 2 |
|
affects expression |
ISO |
14 |
37,273,819 |
37,292,695 |
RGD:6480464 |
CTD |
| G |
Olr484 |
olfactory receptor 484 |
|
affects expression |
ISO |
3 |
69,378,937 |
69,379,884 |
RGD:6480464 |
CTD |
| G |
Parpbp |
PARP1 binding protein |
|
affects expression |
ISO |
7 |
24,777,634 |
24,847,083 |
RGD:6480464 |
CTD |
| G |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
|
decreases expression |
ISO |
20 |
25,379,865 |
25,410,260 |
RGD:6480464 |
CTD |
| G |
Pbld2 |
phenazine biosynthesis-like protein domain containing 2 |
|
affects expression |
ISO |
20 |
25,379,865 |
25,410,260 |
RGD:6480464 |
CTD |
| G |
Phf6 |
PHD finger protein 6 |
|
increases expression |
ISO |
X |
139,850,136 |
139,890,670 |
RGD:6480464 |
CTD |
| G |
Pigz |
phosphatidylinositol glycan anchor biosynthesis, class Z |
|
affects expression |
ISO |
11 |
70,653,993 |
70,673,626 |
RGD:6480464 |
CTD |
| G |
Plekha5 |
pleckstrin homology domain containing, family A member 5 |
|
affects expression |
ISO |
4 |
177,616,038 |
177,784,751 |
RGD:6480464 |
CTD |
| G |
Ppp1r13l |
protein phosphatase 1, regulatory subunit 13 like |
|
affects expression |
ISO |
1 |
78,727,071 |
78,896,831 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
multiple interactions |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
affects expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
decreases response to substance |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
multiple interactions |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prrt2 |
proline-rich transmembrane protein 2 |
|
affects expression |
ISO |
1 |
186,196,585 |
186,199,258 |
RGD:6480464 |
CTD |
| G |
Psca |
prostate stem cell antigen |
|
affects expression |
ISO |
7 |
112,823,862 |
112,835,190 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases activity |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rbbp6 |
retinoblastoma binding protein 6 |
|
affects expression |
ISO |
1 |
181,818,248 |
181,849,942 |
RGD:6480464 |
CTD |
| G |
Rc3h1 |
ring finger and CCCH-type domains 1 |
|
multiple interactions |
ISO |
13 |
76,493,343 |
76,530,107 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
affects expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
RGD1307461 |
similar to RIKEN cDNA 6430571L13 gene; similar to g20 protein |
|
affects expression |
ISO |
8 |
112,581,375 |
112,591,068 |
RGD:6480464 |
CTD |
| G |
RGD1307704 |
similar to RIKEN cDNA 2410016O06 |
|
affects expression |
ISO |
6 |
107,985,351 |
107,987,969 |
RGD:6480464 |
CTD |
| G |
RGD1307752 |
similar to RIKEN cDNA 1110008F13 |
|
affects expression |
ISO |
3 |
147,266,788 |
147,276,798 |
RGD:6480464 |
CTD |
| G |
RGD1310257 |
similar to RIKEN cDNA 6330408A02 gene |
|
affects expression |
ISO |
1 |
73,708,507 |
73,728,764 |
RGD:6480464 |
CTD |
| G |
RGD1310769 |
similar to HSPC288 |
|
affects expression |
ISO |
6 |
109,934,787 |
109,945,923 |
RGD:6480464 |
CTD |
| G |
RGD1311648 |
similar to hypothetical protein FLJ21820 |
|
affects expression |
ISO |
6 |
31,758,976 |
31,845,613 |
RGD:6480464 |
CTD |
| G |
RGD1311892 |
similar to hypothetical protein FLJ10901 |
|
affects expression |
ISO |
13 |
49,249,247 |
49,269,528 |
RGD:6480464 |
CTD |
| G |
RGD1562218 |
similar to RIKEN cDNA 0610039J04 |
|
affects expression |
ISO |
19 |
55,019,196 |
55,033,524 |
RGD:6480464 |
CTD |
| G |
RGD1563482 |
similar to hypothetical protein FLJ38663 |
|
affects expression |
ISO |
12 |
33,377,684 |
33,391,371 |
RGD:6480464 |
CTD |
| G |
RGD1563866 |
RGD1563866 |
|
affects expression |
ISO |
8 |
54,601,616 |
54,606,203 |
RGD:6480464 |
CTD |
| G |
RGD1564036 |
similar to RIKEN cDNA 3010026O09 |
|
affects expression |
ISO |
10 |
35,724,312 |
35,751,257 |
RGD:6480464 |
CTD |
| G |
RGD1564420 |
similar to Hypothetical protein MGC31278 |
|
affects expression |
ISO |
7 |
96,112,349 |
96,169,399 |
RGD:6480464 |
CTD |
| G |
RGD1564450 |
RGD1564450 |
|
affects expression |
ISO |
20 |
5,773,534 |
5,775,502 |
RGD:6480464 |
CTD |
| G |
RGD1565059 |
similar to hypothetical protein E130311K13 |
|
affects expression |
ISO |
2 |
153,709,289 |
153,733,281 |
RGD:6480464 |
CTD |
| G |
RGD1565222 |
similar to RIKEN cDNA 4931414P19 |
|
affects expression |
ISO |
15 |
32,656,277 |
32,688,050 |
RGD:6480464 |
CTD |
| G |
Rimkla |
ribosomal modification protein rimK-like family member A |
|
affects expression |
ISO |
5 |
140,060,901 |
140,085,824 |
RGD:6480464 |
CTD |
| G |
Rint1 |
RAD50 interactor 1 |
|
affects expression |
ISO |
4 |
6,691,863 |
6,728,969 |
RGD:6480464 |
CTD |
| G |
Rmdn2 |
regulator of microtubule dynamics 2 |
|
affects expression |
ISO |
6 |
2,440,492 |
2,514,419 |
RGD:6480464 |
CTD |
| G |
Rmi2 |
RMI2, RecQ mediated genome instability 2, homolog (S. cerevisiae) |
|
affects expression |
ISO |
10 |
4,765,965 |
4,771,062 |
RGD:6480464 |
CTD |
| G |
Rnf26 |
ring finger protein 26 |
|
affects expression |
ISO |
8 |
47,092,910 |
47,095,108 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
decreases expression |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
Sepn1 |
selenoprotein N, 1 |
|
affects expression |
ISO |
5 |
153,295,598 |
153,308,305 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases activity |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spag4 |
sperm associated antigen 4 |
|
affects expression |
ISO |
3 |
146,472,609 |
146,476,953 |
RGD:6480464 |
CTD |
| G |
Spint2 |
serine peptidase inhibitor, Kunitz type, 2 |
|
decreases expression |
ISO |
1 |
84,393,845 |
84,416,299 |
RGD:6480464 |
CTD |
| G |
Sqrdl |
sulfide quinone reductase-like (yeast) |
|
affects expression |
ISO |
3 |
109,743,347 |
109,752,321 |
RGD:6480464 |
CTD |
| G |
Sqrdl |
sulfide quinone reductase-like (yeast) |
|
increases expression |
ISO |
3 |
109,743,347 |
109,752,321 |
RGD:6480464 |
CTD |
| G |
Stab1 |
stabilin 1 |
|
decreases expression |
ISO |
16 |
6,567,583 |
6,597,972 |
RGD:6480464 |
CTD |
| G |
Timd4 |
T-cell immunoglobulin and mucin domain containing 4 |
|
affects expression |
ISO |
10 |
31,892,078 |
31,927,581 |
RGD:6480464 |
CTD |
| G |
Tmem65 |
transmembrane protein 65 |
|
decreases expression |
ISO |
7 |
95,545,429 |
95,587,199 |
RGD:6480464 |
CTD |
| G |
Trappc13 |
trafficking protein particle complex 13 |
|
affects expression |
ISO |
2 |
35,069,282 |
35,100,637 |
RGD:6480464 |
CTD |
| G |
Trex1 |
three prime repair exonuclease 1 |
|
increases expression |
ISO |
8 |
114,071,508 |
114,072,509 |
RGD:6480464 |
CTD |
| G |
Trim2 |
tripartite motif-containing 2 |
|
affects expression |
ISO |
2 |
175,908,880 |
175,974,709 |
RGD:6480464 |
CTD |
| G |
Trim6 |
tripartite motif containing 6 |
|
affects expression |
ISO |
1 |
162,059,220 |
162,094,672 |
RGD:6480464 |
CTD |
| G |
Trmt6 |
tRNA methyltransferase 6 homolog (S. cerevisiae) |
|
affects expression |
ISO |
3 |
120,602,570 |
120,614,291 |
RGD:6480464 |
CTD |
| G |
Ttc3 |
tetratricopeptide repeat domain 3 |
|
multiple interactions |
ISO |
11 |
34,617,072 |
34,659,043 |
RGD:6480464 |
CTD |
| G |
Ttc3 |
tetratricopeptide repeat domain 3 |
|
increases expression |
ISO |
11 |
34,617,072 |
34,659,043 |
RGD:6480464 |
CTD |
| G |
Tuba1b |
tubulin, alpha 1B |
|
multiple interactions |
ISO |
7 |
137,706,858 |
137,709,839 |
RGD:6480464 |
CTD |
| G |
Tuba1b |
tubulin, alpha 1B |
|
decreases expression |
ISO |
7 |
137,706,858 |
137,709,839 |
RGD:6480464 |
CTD |
| G |
Ube2h |
ubiquitin-conjugating enzyme E2H |
|
affects expression |
ISO |
4 |
57,121,159 |
57,216,956 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Wtap |
Wilms tumor 1 associated protein |
|
multiple interactions |
ISO |
1 |
41,891,437 |
41,917,254 |
RGD:6480464 |
CTD |
| G |
XAF1 |
XIAP associated factor-1 |
|
increases response to substance |
ISO |
10 |
59,185,150 |
59,196,549 |
RGD:6480464 |
CTD |
| G |
Zfp395 |
zinc finger protein 395 |
|
affects expression |
ISO |
15 |
44,806,300 |
44,819,787 |
RGD:6480464 |
CTD |
| G |
Zfp867 |
zinc finger protein 867 |
|
affects expression |
ISO |
10 |
45,764,849 |
45,775,258 |
RGD:6480464 |
CTD |
lisinopril dihydrate
|
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
decreases expression |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
increases expression |
EXP |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects response to substance |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Cd2ap |
CD2-associated protein |
|
multiple interactions |
EXP |
9 |
13,827,015 |
13,888,338 |
RGD:6480464 |
CTD |
| G |
Edn1 |
endothelin 1 |
|
decreases secretion |
ISO |
17 |
28,303,886 |
28,309,775 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
EXP |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Havcr1 |
hepatitis A virus cellular receptor 1 |
|
multiple interactions |
EXP |
10 |
31,834,519 |
31,858,019 |
RGD:6480464 |
CTD |
| G |
Hpse |
heparanase |
|
multiple interactions |
EXP |
14 |
10,144,322 |
10,185,115 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
multiple interactions |
EXP |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Mpo |
myeloperoxidase |
|
multiple interactions |
ISO |
10 |
76,085,872 |
76,097,012 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs1 |
nephrosis 1, congenital, Finnish type (nephrin) |
|
multiple interactions |
EXP |
1 |
85,414,492 |
85,444,233 |
RGD:6480464 |
CTD |
| G |
Nphs2 |
nephrosis 2, idiopathic, steroid-resistant |
|
multiple interactions |
EXP |
13 |
71,296,482 |
71,308,868 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
decreases expression |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases expression |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases expression |
EXP |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
Term paths to the root
|